CC

Checkpoint Capital Portfolio holdings

AUM $215M
This Quarter Return
+45.75%
1 Year Return
+27.24%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$143M
AUM Growth
–
Cap. Flow
+$143M
Cap. Flow %
100%
Top 10 Hldgs %
94.29%
Holding
18
New
17
Increased
–
Reduced
–
Closed
–

Top Buys

1
RYTM icon
Rhythm Pharmaceuticals
RYTM
$33.6M
2
ARGX icon
argenx
ARGX
$26.6M
3
CYTK icon
Cytokinetics
CYTK
$19.2M
4
SWTX
SpringWorks Therapeutics
SWTX
$12.4M
5
AXSM icon
Axsome Therapeutics
AXSM
$12.4M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RYTM icon
1
Rhythm Pharmaceuticals
RYTM
$6.85B
$33.6M 20.33%
+730,000
New +$33.6M
ARGX icon
2
argenx
ARGX
$43.6B
$26.6M 16.13%
+70,000
New +$26.6M
CYTK icon
3
Cytokinetics
CYTK
$4.23B
$19.2M 11.63%
+230,000
New +$19.2M
SWTX
4
DELISTED
SpringWorks Therapeutics
SWTX
$12.4M 7.52%
+340,000
New +$12.4M
AXSM icon
5
Axsome Therapeutics
AXSM
$6.05B
$12.4M 7.49%
+155,346
New +$12.4M
IRWD icon
6
Ironwood Pharmaceuticals
IRWD
$214M
$10.1M 6.1%
+880,000
New +$10.1M
MIRM icon
7
Mirum Pharmaceuticals
MIRM
$3.71B
$6.9M 4.18%
+233,659
New +$6.9M
PTGX icon
8
Protagonist Therapeutics
PTGX
$3.67B
$6.12M 3.71%
+266,856
New +$6.12M
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.43B
$4.59M 2.78%
+325,000
New +$4.59M
PHAT icon
10
Phathom Pharmaceuticals
PHAT
$864M
$3.28M 1.99%
+359,446
New +$3.28M
ATYR
11
aTyr Pharma
ATYR
$527M
$2.12M 1.28%
+1,503,554
New +$2.12M
TRVI icon
12
Trevi Therapeutics
TRVI
$883M
$1.73M 1.05%
+1,292,316
New +$1.73M
GHRS icon
13
GH Research
GHRS
$837M
$1.7M 1.03%
+293,945
New +$1.7M
ALLK
14
DELISTED
Allakos
ALLK
$1.21M 0.74%
+444,804
New +$1.21M
IRON icon
15
Disc Medicine
IRON
$2.07B
$578K 0.35%
+10,000
New +$578K
ACRS icon
16
Aclaris Therapeutics
ACRS
$209M
$476K 0.29%
+453,614
New +$476K
EWTX icon
17
Edgewise Therapeutics
EWTX
$1.51B
$361K 0.22%
+33,000
New +$361K
XBI icon
18
SPDR S&P Biotech ETF
XBI
$5.07B
– –
0
– –